Evidence map›Paper›PMID 9858537›Full record

ArticleMolecular and cellular biology1999

Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.

J Starck, A Doubeikovski, S Sarrazin, C Gonnet, G Rao, A Skoultchi, J Godet, I Dusanter-Fourt, F Morle

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. PU.1 and Haematopoietic Cell Fate: Dosage Matters.International journal of cell biology · 2011
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

J StarckCentre de Génétique Moléculaire et Cellulaire, CNRS UMR 5534, 69622 Villeurbanne, France.
A Doubeikovski
S Sarrazin
C Gonnet
G Rao
A Skoultchi
J Godet
I Dusanter-Fourt
F Morle
Laboratoire de Génétique Cellulaire · FRAlbert Einstein College of Medicine · USInserm · FR

Funding

CONTROL OF DIFFERENTIATION OF ERYTHROLEUKEMIC CELLSR01CA016368 · NCI · YESHIVA UNIVERSITY · PI SKOULTCHI, ARTHUR I · 1985 to 2003
$1.7M
CONTROL OF DIFFERENTIATION OF ERYTHROLEUKEMIC CELLSR37CA016368 · NCI · YESHIVA UNIVERSITY · PI SKOULTCHI, ARTHUR I · 1990 to 1997
–
NCI NIH HHS CA16368
6 · The paper itself

Abstract

Spi-1/PU.1 and Fli-1 are two members of the ETS family of transcription factors whose expression is deregulated by proviral insertion in most erythroleukemic cell lines induced by the spleen focus-forming virus (SFFV) and Friend murine leukemia virus (F-MuLV) components of the Friend viral complex, respectively. In this study, we present evidence that transcription of the Fli-1 gene is positively regulated by Spi-1/PU.1 in SFFV-transformed cell lines: (i) all SFFV-transformed cell lines expressing Spi-1/PU.1 are characterized by a specific pattern of Fli-1 gene transcripts initiated in the -200 region instead of position -400 as reported for F-MuLV-transformed cell lines; (ii) these Fli-1 transcripts initiated in the -200 region are downregulated in parallel with that of Spi-1/PU.1 during hexamethylenebisacetamide (HMBA) induced differentiation; and (iii) Fli-1 transcription is upregulated in SFFV cells lines following stable transfection of a Spi-1/PU.1 expression vector. Furthermore, we found by transient transfection assays that the -270/-41 region of the Fli-1 gene displays promoter activity which is transactivated by Spi-1/PU.1. This promoter is strictly dependent on the integrity of two highly conserved ETS DNA binding sites that bind the Spi-1/PU.1 protein in vitro. Finally, we show that transfection of constitutive or inducible Fli-1 expression vectors in SFFV-transformed cells inhibits their erythroid differentiation induced by HMBA. Overall, these data indicate that Fli-1 is a target gene of the Spi-1/PU.1 transcription factor in SFFV-transformed cell lines. We further suggest that deregulated synthesis of Fli-1 may trigger a common mechanism contributing to erythroleukemia induced by either SFFV or F-MuLV.

Indexed as

ErythropoiesisAnimalsBase SequenceBinding SitesCell Line, TransformedConserved SequenceDNA-Binding ProteinsErythroid Precursor CellsFriend murine leukemia virusGene Expression RegulationHumansLeukemia, Erythroblastic, AcuteMiceMolecular Sequence DataPromoter Regions, GeneticProto-Oncogene Protein c-fli-1DNA-Binding ProteinsFli1 protein, mouseProto-Oncogene Protein c-fli-1Proto-Oncogene ProteinsProto-Oncogene Protein Spi-1Trans-Activators

Identifiers

PMID9858537
PMCPMC83871
OpenAlexW1864445396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.